{
    "initial_scores": {
        "ideological_tilt": 0,
        "immigration": 0,
        "executive_power": 0,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 0,
        "social_inclusion": 0
    },
    "critique": "The document is an executive order focused on reducing prescription drug costs by increasing importation of drugs from other countries. It aims to lower drug prices for Americans by facilitating the safe importation of prescription drugs, particularly from Canada, and by allowing the re-importation of insulin products in certain circumstances. The order also emphasizes that it should be implemented in accordance with applicable law and subject to the availability of appropriations.",
    "revised_scores": {
        "ideological_tilt": 1,
        "immigration": 3,
        "executive_power": 1,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": -2,
        "social_inclusion": 0
    }
}